You have 9 free searches left this month | for more free features.

vs-6766

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Boston

Not yet recruiting
  • Breast Cancer
  • +2 more
  • VS-6766
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 3, 2022

Food Effect Trial in Tempe (VS-6766)

Completed
  • Food Effect
  • VS-6766
  • Tempe, Arizona
    Celerion
May 6, 2022

Mesonephric Gynecologic Cancer Trial in United States (VS-6766, Defactinib)

Recruiting
  • Mesonephric Gynecologic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Mar 15, 2023

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic Trial in Chicago (VS-6766, Cetuximab, Pill Diary)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • VS-6766
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Jan 6, 2022

NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

Recruiting
  • NSCLC
  • +3 more
  • Manchester, Greater Manchester, United Kingdom
  • +4 more
Mar 18, 2022